Literature DB >> 21352972

Predictors, causes, and consequences of conversions in robotically enhanced totally endoscopic coronary artery bypass graft surgery.

Thomas Schachner1, Nikolaos Bonaros, Dominik Wiedemann, Eric J Lehr, Felix Weidinger, Gudrun Feuchtner, David Zimrin, Johannes Bonatti.   

Abstract

BACKGROUND: Totally endoscopic coronary artery bypass graft surgery (TECAB), using the da Vinci telemanipulator, has become a reproducible operation at dedicated centers. As in every endoscopic operation, conversion is an important and probably inevitable issue.
METHODS: We performed robotic TECAB in 326 patients (age, 60 years; range, 31 to 90 years); 242 were single-vessel and 84 were multivessel TECAB.
RESULTS: Forty-six of 326 patients (14%) were converted to a larger incision (minithoracotomy, n = 5; sternotomy, n = 41). Left internal mammary artery injury (n = 7), epicardial injury (n = 4), balloon endoocclusion problems (n = 7), and anastomotic problems (n = 18) were common reasons for conversions. Conversion rate was significantly less for single-vessel versus multivessel TECABs (10% versus 25%; p = 0.001). Non-learning-curve case (7% versus 21%; p < 0.001) and transthoracic assistance (11% versus 22%; p = 0.018) were associated with lower conversion rates. In multivariate analysis, learning-curve case was the only independent predictor of conversion (p = 0.005). Conversion translated into increased packed red blood cell transfusion in the operating room (3 versus 0 units; p < 0.001), longer ventilation time (14 versus 8 hours; p < 0.001), and intensive care unit stay (45 versus 20 hours; p = 0.001). Hospital mortality was 0.6% in this series, with 1 patient in the conversion group (2.2%) and 1 patient in the nonconverted group (0.4%; not significant). Five-year survival was 98% in nonconverted patients and 88% in converted patients (p = 0.018). There was no difference in freedom from angina or freedom from major adverse cardiac and cerebral events.
CONCLUSIONS: Conversion in TECAB is primarily learning curve-dependent and associated with increased morbidity, but does not significantly affect hospital mortality. Both nonconverted and converted patients show good long-term survival, which is comparable to patients undergoing open sternotomy coronary artery bypass grafting. Long-term freedom from angina or freedom from major adverse cardiac and cerebral events is not influenced by conversion.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21352972     DOI: 10.1016/j.athoracsur.2010.10.072

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Robotically assisted totally endoscopic coronary artery bypass surgery.

Authors:  Leonardo Secchin Canale; Stephanie Mick; Tomislav Mihaljevic; Ravi Nair; Johannes Bonatti
Journal:  J Thorac Dis       Date:  2013-11       Impact factor: 2.895

2.  The state of robotic cardiac surgery in Europe.

Authors:  Matteo Pettinari; Emiliano Navarra; Philippe Noirhomme; Herbert Gutermann
Journal:  Ann Cardiothorac Surg       Date:  2017-01

3.  Initial experience with internal mammary artery harvesting with the da Vinci Surgical System for minimally invasive direct coronary artery bypass.

Authors:  Tomoyuki Fujita; Hiroki Hata; Yusuke Shimahara; Shunsuke Sato; Junjiro Kobayashi
Journal:  Surg Today       Date:  2014-01-15       Impact factor: 2.549

4.  Robotic Cardiac Surgery: The Future Gold Standard or An Unnecessary Extravagance?

Authors:  Amer Harky; Syed Mohammad Asim Hussain
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27

5.  Systematic review of robotic-assisted, totally endoscopic coronary artery bypass grafting.

Authors:  Michael Seco; J James B Edelman; Tristan D Yan; Michael K Wilson; Paul G Bannon; Michael P Vallely
Journal:  Ann Cardiothorac Surg       Date:  2013-07

6.  Minimally invasive surgical techniques in the era of hybrid coronary revascularization: additional benefits for the elderly patients?

Authors:  Antonio Nenna; Mario Lusini; Salvatore Matteo Greco; Elvio Covino; Massimo Chello
Journal:  J Geriatr Cardiol       Date:  2016-10       Impact factor: 3.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.